CrowdSecLive Exploit Tracker
Limited ExploitationCVE-2025-59474Public Exploit

Jenkins - Authorization Bypass (CVE-2025-59474)

PublishedSep 17, 2025
First SeenOct 17, 2025
Last Seen
Reported
CVSS5.3
cicd

Description

Jenkins 2.527 and earlier, LTS 2.516.2 and earlier does not perform a permission check in the sidepanel of a page intentionally accessible to users lacking Overall/Read permission, allowing attackers without Overall/Read permission to list agent names through its sidepanel executors widget.

psychologyCrowdSec Analysis

CVE-2025-59474 is a vulnerability in Jenkins that allows attackers without Overall/Read permission to enumerate agent names via the sidepanel executors widget. This information disclosure flaw could aid threat actors in reconnaissance efforts, potentially facilitating further targeted attacks against Jenkins environments.

CrowdSec has been tracking this vulnerability and its exploits since 15th of October 2025.

CrowdSec network observations suggest that most exploitation of CVE-2025-59474 involves focused reconnaissance to identify viable targets. Attackers typically tailor their campaigns based on system exposure and configuration. It is unlikely that a given attack is accidental. CrowdSec data also reveals a clear uptick in attacks involving CVE-2025-59474 over the past week. Activity is above the usual baseline, suggesting growing attention from attackers. This may reflect rising awareness, recent exploit releases, or expanded targeting efforts.

Attackers probe Jenkins endpoints such as /securityRealm/signup and /jenkins/securityRealm/signup to access the sidepanel and enumerate agent names via the "Build Executor Status" widget, even without Overall/Read permissions.

lock

Full Intelligence Available

Connect your API key to access CrowdSec scores, exploit timelines, and attacker IPs.

EventDate
CVE Published2025-09-17
Rule Released2025-10-15
CrowdSec First Seen2025-10-17

Remediation & Protection

lock to download blocklists, subscribe to firewalls, and access IP intelligence.